BRINGING YOU INFORMATION.  PROVIDING YOU A PLATFORM.

 

 
THE PHARMA REVIEW (SEPTEMBER OCTOBER 2012)

Evaluation of Preventive and Therapeutic Measures in Dengue Survey: Vital Role of Pharmacists

Pradnya Palekar Shanbhag1, Mahesh V. Abhyankar2, Bhavin S. Dedhia2, Pranav M. Agte2 & Prafulla V. Belge2

Introduction:
 
Dengue is a mosquito-borne disease caused by one of the four serotypes of dengue viruses. It is characterized by dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS). Dengue is now endemic in 112 countries of Africa, America and Asia. Every year about 50-100 million cases of dengue infection, 500,000 cases of DHF and at least 12,000 deaths occur worldwide; ninety percent of these deaths occur in children less than 15 years of age. Without proper treatment, DHF case fatality rates can exceed 20%. With modern intensive supportive therapy, such rates can be reduced to less than 1%. Better understanding of immunopathogenesis in this immunologically distinct group is needed.

 

 

Go to Content Index Page

PHARMA REVIEW - ARTICLES ARCHIVE ( COMPLETE LIST)

 

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 9811195411
Email: kongposhpub@gmail.com, Website: http://www.kppub.com

 
 
 
 

Copyright KONGPOSH PUBLICATIONS Pvt. Ltd.